This inventor holds 2 USPTO granted patents and 4 published patent applications. Top assignees: Kenjockety Biotechnology, Inc., William Robert Arathoon Living Trust Dated August 29, 2016. Active years: 2025-2026.
Company Filing History:
1 out of 1 
1 out of 1 Years Active: 2025-2026
Title: Paul David Ponath: Innovator in Cancer Treatment
Introduction
Paul David Ponath is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of cancer treatment through his innovative work in multi-specific antibodies. His research focuses on developing methods to target cancer-associated antigens effectively.
Latest Patents
Ponath holds a patent for "Efflux pump-cancer antigen multi-specific antibodies and compositions, reagents, kits and methods related thereto." This patent provides multi-specific antibodies that target both a cellular efflux pump and a cancer-associated antigen. The invention includes pharmaceutical compositions, nucleic acids, recombinant expression vectors, and kits that incorporate these multi-specific antibodies. Additionally, it outlines methods for treating cancer by administering these antibodies to patients, as well as techniques for generating the antibodies and related reagents.
Career Highlights
Paul David Ponath is associated with the William Robert Arathoon Living Trust Dated August 29, 2016. His work in this organization has allowed him to focus on groundbreaking research in cancer therapies. His innovative approach has the potential to improve treatment outcomes for cancer patients.
Collaborations
Ponath collaborates with notable individuals in his field, including William Robert Arathoon and Evan Matthew Bishop. These partnerships enhance the research and development of effective cancer treatments.
Conclusion
Paul David Ponath's contributions to cancer treatment through his innovative patents and collaborations highlight his commitment to advancing medical science. His work continues to pave the way for new therapeutic approaches in oncology.